Aurinia Pharmaceuticals on the hosts conference for the discussion of Aur200 phase -1 study results on June 30, 2025

Your email address will not be published. Required fields are marked *

Name  *

Email  *

Website

Add Comment *

Save my name, email, and website in this browser for the next time I comment.

Post Comment